The Limited Times

Now you can see non-English news...

Russia announces production agreements for Sputnik V in Europe, notably in France

2021-03-15T10:52:38.377Z


The Russian Sovereign Fund (RDIF) announced Monday that agreements for the production of the anti-Covid Sputnik V vaccine have been reached " with companies from Italy, Spain, France and Germany  ", pending its approval in the EU. “ There are currently other talks going on to increase production in the EU. This will make it possible to start supplying the single European market with Sputnik V upo


The Russian Sovereign Fund (RDIF) announced Monday that agreements for the production of the anti-Covid Sputnik V vaccine have been reached "

with companies from Italy, Spain, France and Germany

 ", pending its approval in the EU.

There are currently other talks going on to increase production in the EU.

This will make it possible to start supplying the single European market with Sputnik V upon authorization by the European Medicines Agency

 ”(EMA), the head of the Fund, Kirill Dmitriev, said in a statement.

Read also: The Sputnik V vaccine will be produced in Italy

The head of RDIF, which financed the development of this vaccine, did not indicate the name of the European groups with which agreements had been reached.

On March 9, a first production agreement was announced in Italy with the Italian-Swiss pharmaceutical company Adienne, which is to produce the vaccine in Lombardy.

Sputnik V is not yet authorized in the European Union, but has taken a step forward with the start of its review by the Amsterdam-based MEA.

After this announcement, the Russian authorities said they were ready to provide vaccines to 50 million Europeans from June.

In addition, Mr. Dmitriev said Monday that Russia was also ready to "

start the supply of EU countries that will authorize Sputnik V independently

 " of the EMA, like Hungary.

Initially greeted with skepticism abroad because announced as a success in the summer of 2020 after tests on only a few dozen people, Sputnik V has since convinced some fifty countries.

Its reliability was validated in February by the scientific journal The Lancet.

The development of the vaccine had been entrusted to state institutions, and is celebrated in Moscow as a historic success for Russia under Vladimir Putin.

The choice of the name is also highly symbolic.

A tribute to the first satellite to have been put into orbit in 1957 by the USSR, it recalls a scientific feat and a historic setback for the American rival.

Read also: Covid-19: Sputnik V, a very political Russian vaccine

Russia also regularly accuses the West of campaigning against Sputnik V, insinuating that Moscow was orchestrating vaccine diplomacy intended to sow discord in Europe.

The EU is facing difficulties in the supply of anti-Covid vaccines developed by Western pharmaceutical groups.

Source: lefigaro

All business articles on 2021-03-15

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.